About
Develops scalable lipid nanoparticle (LNP) delivery platforms engineered to enable nucleic acid medicines such as mRNA, siRNA, and DNA to target extrahepatic tissues with improved potency and safety.
Explore NanoVation Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.